Sorensen Mel is the founder of Galera Therapeutics. Galera Therapeutics has raised $11M in total funding. Latest round: Series A.
J. Mel Sorensen is the President and CEO of Galera Therapeutics, a biotechnology company focused on developing small-molecule therapeutics. He also serves as a director for the company and is involved in their clinical development and capital transactions. Galera Therapeutics is headquartered in Malvern, Pennsylvania.
Full founder directory · Investor directory · Company funding database · Fundraising library